Skip to main content
SpringerLink
Log in

Novel Combined Preparation and Investigation of Bergenin-Loaded Albumin Nanoparticles for the Treatment of Acute Lung Injury: In Vitro and In Vivo Evaluations

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

A new method for targeting lung infections is of great interest using biodegradable nanoparticles. In this study, bergenin-loaded BSA NPs were developed against lung injury. Briefly, bergenin-loaded bovine serum albumin nanoparticles (BG@BSA NPs) were synthesized and characterized. HPLC recorded the major peak of bergenin. UV–Vis spectra had an absorbance at 376 nm. XRD revealed the presence of crystalline particles. FTIR confirmed the occurrence of functionalized molecules in the synthesized NPs. The particles were highly stable with a net negative charge of − 24.2. The morphology of NPs was determined by SEM and TEM. The mean particle size was 124.26 nm. The production of NO by NR8383 cells was decreased by BG@BSA NPs. Also, in mice, lipopolysaccharide-mediated acute lung inflammation was induced. BG@BSA NPs reduced macrophages and neutrophils in BALF and remarkably enhanced wet weight-to-dry weight (W/D) ratios and myeloperoxidase (MPO) activity. Further, BG@BSA NPs inhibited the production of inflammatory cells as well as tumor necrosis factor. The histopathological studies revealed that the damage and neutrophil infiltration were greatly inhibited by BG@BSA NPs. This indicates that BG@BSA NPs may be used to treat lung infections. Therefore, this study has given new insight into producing an active drug for the treatment of lung-associated diseases in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

References

  1. Rubenfeld, G.D., and M.S. Herridge. 2007. Epidemiology and outcomes of acute lung injury. Chest 131: 554–559.

    Article  Google Scholar 

  2. Matthay, M.A. 2008. Treatment of acute lung injury: Clinical and experimental studies. Proceedings of the American Thoracic Society 5: 297–301.

    Article  Google Scholar 

  3. Girard, T.D., and G.B. Bernard. 2007. Mechanical ventilation in ARDS: A state-of-the-art review. Chest 131: 921–933.

    Article  Google Scholar 

  4. Sadikot, R.T., J.W. Christman, and T.S. Blackwell. 2004. Molecular targets for modulating lung inflammation and injury. Current Drug Targets 5: 581–588.

    Article  CAS  Google Scholar 

  5. Yuan, Z., M. Syed, D. Panchal, M. Joo, C. Bedi, S. Lim, H. Onyuksel, I. Rubinstein, M. Colonna, and R.T. Sadikot. 2016. TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine. American Journal of Physiology. Lung Cellular and Molecular Physiology 310: L426–L438.

    Article  Google Scholar 

  6. Sadikot, R.T., and I. Rubinstein. 2009. Long-acting, multi-targeted nanomedicine: Addressing unmet medical need in acute lung injury. Journal of Biomedical Nanotechnology 5: 614–619.

    Article  CAS  Google Scholar 

  7. Foldvari, M., and N. Elsabahy. 2011. Nanotechnology enables superior medical therapies. Current Drug Delivery 8: 225–226.

    Article  CAS  Google Scholar 

  8. Dames, P., B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck D, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, and J. Rosenecker. 2007. Targeted delivery of magnetic aerosol droplets to the lung. Nature Nanotechnology. 2(8):495–499.

  9. Kim, B.Y., J.T. Rutka, and W.C. Chan. 2010. Nanomedicine. New England Journal of Medicine 363: 2434–2443.

    Article  CAS  Google Scholar 

  10. Singh, S. 2010. Nanomedicine-nanoscale drugs and delivery systems. Journal of Nanoscience and Nanotechnology 10: 7906–7918.

    Article  CAS  Google Scholar 

  11. Buxton, D.B. 2009. Nanomedicine for the management of lung and blood diseases. Nanomedicine 4: 331–339.

    Article  CAS  Google Scholar 

  12. Roy, I., and N. Vij. 2010. Nanodelivery in airway diseases: Challenges and therapeutic applications. Nanomedicine 6: 237–244.

    Article  CAS  Google Scholar 

  13. Klingler, C., B.W. Müller, and H. Steckel. 2009. Insulin-micro- and nanoparticles for pulmonary delivery. International Journal of Pharmaceutics 377 (377): 173–179.

    Article  CAS  Google Scholar 

  14. Shuvaev, V.V., and V.R. Muzykantov. 2011. Targeted modulation of reactive oxygen species in the vascular endothelium. Journal of Controlled Release 153: 56–63.

    Article  CAS  Google Scholar 

  15. Sung, J.C., B.L. Pulliam, and D.A. Edwards. 2007. Nanoparticles for drug delivery to the lungs. Trends in Biotechnology 25: 563–570.

    Article  CAS  Google Scholar 

  16. Schleh, C., B. Rothen-Rutishauser, and W.G. Kreyling. 2011. The influence of pulmonary surfactant on nanoparticulate drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 770: 350–352.

    Article  Google Scholar 

  17. Weber, C., J. Kreuter, and K. Langer. 2000. Desolvation process and surface characteristics of HAS-nanoparticles. International Journal of Pharmaceutics 196: 197–200.

    Article  CAS  Google Scholar 

  18. Bhushan, B., P. Dubey, S. Uday Kumar, A. Sachdev, I. Mataia, and P. Gopinath. 2015. Bionanotherapeutics: niclosamide encapsulated albumin nanoparticles as a novel drug delivery system for cancer therapy. RSC Advances 5:12078.

  19. Hossain, M., A. Y. Khan, G. S. Kumar. 2011. Interaction of the anticancer plant alkaloid sanguinarine with bovine serum albumin. PLoS One 6: e18333.

  20. Maltas, E. 2014. Binding interactions of niclosamide with serum proteins. Journal of Food and Drug Analysis 22: 549–555.

    Article  CAS  Google Scholar 

  21. Abdelwahed, W., G. Degobert, S. Stainmesse, and H. Fessi. 2006. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Delivery Rev. 58: 1688–1713.

    Article  CAS  Google Scholar 

  22. Peer, D., J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer. 2007. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2: 751–760.

    Article  CAS  Google Scholar 

  23. Guo, H.,  S. Fei, Y. Zhang, Y.u. Zhang, J. Gou, L. Zhang, H. He, T. Yin, Y. Wang, and X. Tang. 2016. Teniposide-loaded multilayer modified albumin nanoparticles with increased passive delivery to the lung. RSC Advances 6: 81110.

  24. Sripriyalakshmi, S.,  C. H. Anjali, C. G. P. Doss, B. Rajith, and A. Ravindran. 2014. BSA nanoparticle loaded atorvastatin calcium--a new facet for an old drug. PLoS One 9: e86317.

  25. Wang, Y., W. Huang, J. Zhang, M. Yang, Q. Qi, K. Wang, A. Lia, and Z. Zhao. 2016. The therapeutic effect of Bletilla striata extracts on LPS-induced acute lung injury by regulation of inflammation and oxidation. RSC Advances 6: 89338.

    Article  CAS  Google Scholar 

  26. Nanashima, N., M. Akita, T. Yamada, T. Shimizu, H. Nakano, Y. Fan, and S. Tsuchida. 2008. The hairless phenotype of the Hirosaki hairless rat is due to the deletion of an 80-kb genomic DNA containing five basic keratin genes. Journal of Biological Chemistry 283: 16868–16875.

    Article  CAS  Google Scholar 

  27. Ma, C., J. Liu, R. Qu, S. Ma, and Chin. 2014. Tectorigenin inhibits the inflammation of LPS-induced acute lung injury in mice. Chinese Journal of Natural Medicines 12:841–846.

  28. Huang, X., Y. Liu, Y. Lu, and C. Ma. 2015. Anti-inflammatory effects of eugenol on lipopolysaccharide-induced inflammatory reaction in acute lung injury via regulating inflammation and redox status. International Immunopharmacology 26: 265–271.

    Article  CAS  Google Scholar 

  29. Türüt, H., H. Ciralik, M. Kilinc, D. Ozbag, and S.S. Imrek. 2009. Effects of early administration of dexamethasone, N-acetylcysteine and aprotinin on inflammatory and oxidant-antioxidant status after lung contusion in rats. Injury 40: 521–527.

    Article  Google Scholar 

  30. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.

    Article  CAS  Google Scholar 

  31. Koul, A., V. Bhatia, and M.P. Bansal. 2001. Effect of alpha-tocopherol on pulmonary antioxidant defence system and lipid peroxidation in cigarette smoke inhaling mice. BMC Biochemistry 2: 1471–2091.

    Article  Google Scholar 

  32. Jiang, W., F. Luo, Q. Lu, J. Liu, P. Li, X. Wang, Y. Fu, K. Hao, T. Yan, and X. Ding. 2016. Chemico-Biological Interactions 243: 127–134.

    Article  CAS  Google Scholar 

  33. Ma, J., H. Xu, J. Wu, C. Qu, F. Sun, and S. Xu. 2015. Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation. International Immunopharmacology 29: 708–713.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, First People’s Hospital of Wenling, Wenling, 317500, People’s Republic of China

    Hui Lin, Hongwang Yan, Hongxi Yu & Liqun Shan

  2. Department of Neurosurgery, The Kaifeng Central Hospital of Xinxiang Medical University, Kaifeng, 475000, People’s Republic of China

    Pengfei Wang & Wanhong Zhang

  3. Pulmonary and Critical Care Medicine, First People’s Hospital of Wenling, Wenling, 317500, People’s Republic of China

    Lingqiao Yan, Hui Chen & Mindan Xie

Authors
  1. Hui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pengfei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wanhong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongwang Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hongxi Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lingqiao Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mindan Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Liqun Shan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Lingqiao Yan contributed to the conception and coordination of the study, the assessment of the quality of trials, and drafting the manuscript. Hui Chen contributed to the extracting and screening of all references for eligibility, the assessment of the quality of trials, and drafting the manuscript. Mindan Xie contributed to the conception and coordination of the study, the assessment of the quality of trials, and drafting the manuscript.

Corresponding author

Correspondence to Mindan Xie.

Ethics declarations

Ethics Approval and Consent to Participate

In this study, all animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of First People’s Hospital of Wenling and all experiments were conducted with the approval of the Animal Ethical Committee at the First People’s Hospital of Wenling, People’s Republic of China.

Consent for Publication

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Hui Lin, Pengfei Wang and Wanhong Zhang contributed equally to this study

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, H., Wang, P., Zhang, W. et al. Novel Combined Preparation and Investigation of Bergenin-Loaded Albumin Nanoparticles for the Treatment of Acute Lung Injury: In Vitro and In Vivo Evaluations. Inflammation 45, 428–444 (2022). https://doi.org/10.1007/s10753-021-01556-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-021-01556-2

KEY WORDS

Search

Navigation